TR200100952T2 - alfa-2-antagonistler olarak üç halkalı delta3-piperidinler - Google Patents

alfa-2-antagonistler olarak üç halkalı delta3-piperidinler

Info

Publication number
TR200100952T2
TR200100952T2 TR2001/00952T TR200100952T TR200100952T2 TR 200100952 T2 TR200100952 T2 TR 200100952T2 TR 2001/00952 T TR2001/00952 T TR 2001/00952T TR 200100952 T TR200100952 T TR 200100952T TR 200100952 T2 TR200100952 T2 TR 200100952T2
Authority
TR
Turkey
Prior art keywords
alpha
delta3
piperidines
antagonists
ring
Prior art date
Application number
TR2001/00952T
Other languages
English (en)
Inventor
Edmond Josephine Kennis Ludo
Maria Alfons Van Den Keybus Frans
Carolus Mertens Josephus
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of TR200100952T2 publication Critical patent/TR200100952T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Mevcut bulus, formül (I)'in bilesikleri, N-oksit formlari, farmasötik açidan kabul edilen ekleme tuzlari ve bunlarin stereokimyasal izomerik formlari ile ilgili olup, özelligi, Alk'in C1-6 alkanediil; n'nin 1 veya 2 olmasi, X1'in -O-, -S-, -S(=O) veya -S(=O)2-; her R1'in bagimsiz olarak hidrojen, halojen, C1-6 alkil, nitro, hidroksi veya C1-4 alkiloksi olmasi, D'nin istege göre, merkezi alfa 2-adrenoseptör antagonist aktivitesi olan heterosiklik bir 2H-benzopiranon, bir benzamit, bir benzofenon veya bir fenoksifenil içeren ikameli bir tek, çift veya üç halkali azot olmasidir. Ayrica bunlarin hazirlanmasi, farmasötik olarak kullanilmasi ve bilesimleri ile de ilgilidir. (FORMÜL VAR)
TR2001/00952T 1998-10-06 1999-10-01 alfa-2-antagonistler olarak üç halkalı delta3-piperidinler TR200100952T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98203370 1998-10-06

Publications (1)

Publication Number Publication Date
TR200100952T2 true TR200100952T2 (tr) 2001-10-22

Family

ID=8234191

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00952T TR200100952T2 (tr) 1998-10-06 1999-10-01 alfa-2-antagonistler olarak üç halkalı delta3-piperidinler

Country Status (30)

Country Link
US (1) US6495555B1 (tr)
EP (1) EP1119571B1 (tr)
JP (1) JP4590101B2 (tr)
KR (1) KR20010071843A (tr)
CN (1) CN1131230C (tr)
AR (1) AR024216A1 (tr)
AT (1) ATE232869T1 (tr)
AU (1) AU760502B2 (tr)
BG (1) BG64872B1 (tr)
BR (1) BR9913507A (tr)
CA (1) CA2345622C (tr)
CZ (1) CZ20011104A3 (tr)
DE (1) DE69905478T2 (tr)
DK (1) DK1119571T3 (tr)
EE (1) EE04770B1 (tr)
ES (1) ES2193751T3 (tr)
HU (1) HUP0104002A3 (tr)
ID (1) ID28032A (tr)
IL (1) IL142443A0 (tr)
NO (1) NO20011270L (tr)
NZ (1) NZ510115A (tr)
PL (1) PL347894A1 (tr)
PT (1) PT1119571E (tr)
RU (1) RU2230744C2 (tr)
SI (1) SI1119571T1 (tr)
SK (1) SK285585B6 (tr)
TR (1) TR200100952T2 (tr)
TW (1) TWI248441B (tr)
UA (1) UA69420C2 (tr)
WO (1) WO2000020421A2 (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID28451A (id) * 1998-10-06 2001-05-24 Janssen Pharmaceutica Nv Trisiklik piperidin-δ3 sebagai bahan farmasi
ATE521593T1 (de) * 2002-04-03 2011-09-15 Orion Corp Verwendung eines alfa2-adrenorezeptorantagonisten bei mit dem zns zusammenhängenden erkrankungen
WO2005100355A1 (ja) 2004-04-12 2005-10-27 Taisho Pharmaceutical Co., Ltd. 環状アミン化合物
WO2006006740A1 (ja) * 2004-07-14 2006-01-19 Japan Tobacco Inc. ３−アミノベンズアミド化合物及びバニロイド受容体１型(ｖｒ１)活性阻害剤
MX2007000480A (es) * 2004-07-15 2007-03-29 Japan Tobacco Inc Compuesto de benzamida fusionado e inhibidor de actividad de receptor de vainilloide 1.
US7906508B2 (en) * 2005-12-28 2011-03-15 Japan Tobacco Inc. 3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (VRI) activity
US8399465B2 (en) 2009-05-14 2013-03-19 Janssen Pharmaceutica Nv Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene A4 hydrolase
EP3083610A1 (de) 2013-12-19 2016-10-26 Bayer Pharma Aktiengesellschaft Substituierte bipiperidinyl-derivate als adrenrezeptor alpha 2c antagonisten
KR20160098424A (ko) * 2013-12-19 2016-08-18 바이엘 파마 악티엔게젤샤프트 치환된 피페리디닐-테트라히드로퀴놀린
CR20160276A (es) * 2013-12-19 2016-10-20 Bayer Pharma AG "piperidiniltetrahidroquinolinas sustituidas y su uso como antagonistas de los adenoreceptores alpha-2c"
CN114276359B (zh) * 2022-01-05 2023-05-05 浙江大学 一种1,2,3,4-四氢苯并[4,5]呋喃[2,3-c]吡啶衍生物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU926914A1 (ru) * 1980-05-26 1992-04-23 Научно-исследовательский институт фармакологии АМН СССР Производные 1,2,3,4-тетрагидробензофуро[3,2-с]-пиридина или хлоргидрат, обладающие р дом свойств анальгетиков и антагонистов морфина
DE3522959A1 (de) * 1985-06-27 1987-01-08 Merck Patent Gmbh Indolderivate
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
US4985422A (en) * 1988-04-27 1991-01-15 Glaxo Group Limited Lactam derivatives
US4971974A (en) * 1988-06-16 1990-11-20 Neurex Corporation Benzothiophenes as appetite suppressants
US5100891A (en) * 1991-01-18 1992-03-31 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
AU735764B2 (en) * 1996-12-06 2001-07-12 Abbott Laboratories Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds
DE69829317T2 (de) 1997-12-25 2006-04-06 Meiji Seika Kaisha Ltd. Tetrahydrobenzindol-derivate
ID28451A (id) * 1998-10-06 2001-05-24 Janssen Pharmaceutica Nv Trisiklik piperidin-δ3 sebagai bahan farmasi

Also Published As

Publication number Publication date
DE69905478D1 (de) 2003-03-27
WO2000020421A2 (en) 2000-04-13
NO20011270D0 (no) 2001-03-13
ES2193751T3 (es) 2003-11-01
BG64872B1 (bg) 2006-07-31
TWI248441B (en) 2006-02-01
NO20011270L (no) 2001-03-13
JP4590101B2 (ja) 2010-12-01
UA69420C2 (uk) 2004-09-15
WO2000020421A3 (en) 2000-08-03
SK285585B6 (sk) 2007-04-05
PL347894A1 (en) 2002-04-22
SK4322001A3 (en) 2002-01-07
BR9913507A (pt) 2001-06-05
AU760502B2 (en) 2003-05-15
HUP0104002A2 (hu) 2002-03-28
KR20010071843A (ko) 2001-07-31
EP1119571B1 (en) 2003-02-19
CN1332744A (zh) 2002-01-23
DK1119571T3 (da) 2003-05-26
EE200100209A (et) 2002-06-17
CA2345622C (en) 2007-12-04
EE04770B1 (et) 2007-02-15
CZ20011104A3 (cs) 2001-12-12
HK1038010A1 (en) 2002-03-01
US6495555B1 (en) 2002-12-17
RU2230744C2 (ru) 2004-06-20
PT1119571E (pt) 2003-06-30
JP2002526545A (ja) 2002-08-20
AR024216A1 (es) 2002-09-25
SI1119571T1 (en) 2003-08-31
CN1131230C (zh) 2003-12-17
AU6334199A (en) 2000-04-26
NZ510115A (en) 2002-11-26
HUP0104002A3 (en) 2003-12-29
ID28032A (id) 2001-05-03
EP1119571A2 (en) 2001-08-01
ATE232869T1 (de) 2003-03-15
IL142443A0 (en) 2002-03-10
CA2345622A1 (en) 2000-04-13
DE69905478T2 (de) 2004-03-18
BG105332A (en) 2001-11-30

Similar Documents

Publication Publication Date Title
IL106900A0 (en) Amino acid derivatives,their manufacture and pharmaceutical compositions containing them
NO20001002L (no) Oxo-substituerte forbindelser, fremgangsmõte for fremstilling, og sammensetninger og metoder for hemming av PARP aktiviteter
ES2159738T3 (es) Derivados de benzamida y su uso como antagonistas de vasopresina.
TR200100952T2 (tr) alfa-2-antagonistler olarak üç halkalı delta3-piperidinler
ES2070175T3 (es) Derivados de acido 4-oxoquinolino-3-carboxilico, su preparacion y su uso.
ES8303360A1 (es) Un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina.
TR199900486T2 (tr) Aziniloksi ve fenoksi-diaril-karbonasit türevleri.
DE69507293D1 (de) Benzamid-derivate als vasopressin-antagonisten
TR199900644T2 (tr) 1,2,3,4-Tetrahidro-benzofuro [3,2-c] piridin türevleri.
MY129176A (en) Tetrahydro gamma-carbolines
ATE218563T1 (de) Piperidinone als tachykininantagoniste
ATE21246T1 (de) Substituierte imidazol-derivate mit pharmakologischer wirkung sowie ihre herstellung und verwendung.
ES8301234A1 (es) Un procedimiento para la preparacion de un compuesto de quinazolina.
MY130950A (en) 4-(1h-indol-1-yl)-1-piperidinyl derivatives
TR200100953T2 (tr) Farmasötikler olarak üç halkalı delta3-piperidinler
WO2001064659A3 (en) Indane derivatives and their use as cell adhesion inhibitors
HU0301173D0 (en) Quinazoline derivatives and their use for the preparation of pharmaceutical compositions inhibiting parp enzyme
UA41350C2 (uk) Похідна морфоліну або її фармацевтично прийнятна сіль та фармацевтична композиція на її основі
TR200100954T2 (tr) Alfa-2-antagonistler olarak benzotiyeno[3.2-c]-piridinler
TR200003142T2 (tr) Yeni oktahidro-6,10-diokso-6H-piridazino [1,2-A] [1,2] diazepin-1-karboksilik asit türevleri.
TR200101813T2 (tr) Alfa2-Antagonistleri olarak benzisoksazoller ve fenonlar
TR199900984T2 (tr) Benzensülfonamid türevleri ve adi geçen türevleri içeren ilaçlar.
DE3660959D1 (de) Benz-trisubstituted 2-aminotetralins
UY26971A1 (es) Nuevos antagonistas de neuroquinina, procedimiento para su preparación y composiciones farmacéuticas que contienen estos compuestos
ECSP961920A (es) Nuevos derivados de aminoacidos, procedimiento para su preparacion y composiciones farmaceuticas que contienen estos compuestos